Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Stryker Corporation (SYK : NYSE)

• Company Description    Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. Number of Employees: 46,000

• Price / Volume Information    Yesterday's Closing Price: $232.25 Daily Weekly Monthly 20 Day Moving Average: 1,691,269 shares Shares Outstanding: 378.15 (millions) Market Capitalization: $87,826.27 (millions) Beta: 0.99 52 Week High: $281.16 52 Week Low: $224.02 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -13.99% -3.14% 12 Week -9.88% -0.93% Year To Date -13.15% 5.32%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2825 AIRVIEW BLVD - KALAMAZOO,MI 49002 USA ph: 269-385-2600 fax: 269-385-1062 preston.wells@stryker.com http://www.strykercorp.com

• General Corporate Information    Officers Kevin A. Lobo - Chairman and Chief Executive Officer and President Glenn S. Boehnlein - Vice President; Chief Financial Officer Allan C. Golston - Director Mary K. Brainerd - Director Giovanni Caforio - Director Peer Information Stryker Corporation (BJCT) Stryker Corporation (CADMQ) Stryker Corporation (APNO) Stryker Corporation (UPDC) Stryker Corporation (IMTIQ) Stryker Corporation (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 863667101 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 07/26/22 Share - Related Items Shares Outstanding: 378.15 Most Recent Split Date: 5.00 (2.00:1) Beta: 0.99 Market Capitalization: $87,826.27 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 1.20% Current Fiscal Quarter EPS Consensus Estimate: $2.29 Indicated Annual Dividend: $2.78 Current Fiscal Year EPS Consensus Estimate: $9.64 Payout Ratio: 0.30 Number of Estimates in the Fiscal Year Consensus: 12.00 Change In Payout Ratio: 0.01 Estmated Long-Term EPS Growth Rate: 9.15% Last Dividend Paid: 03/30/2022 - $0.69 Next EPS Report Date: 07/26/22

• Fundamental Ratios P/E Current FY Estimate: 24.09 Trailing 12 Months: 25.44 PEG Ratio: 2.63 Price Ratios Price/Book: 5.84 Price/Cash Flow: 19.64 Price / Sales: 5.04 EPS Growth vs. Year Ago Period: 2.07% vs. Previous Quarter: -27.31% Sales Growth vs. Year Ago Period: 8.15% vs. Previous Quarter: -9.06% ROE 03/31/22 - 24.09 12/31/21 - 24.65 09/30/21 - 25.73 ROA 03/31/22 - 10.07 12/31/21 - 10.22 09/30/21 - 10.35 Current Ratio 03/31/22 - 1.98 12/31/21 - 2.20 09/30/21 - 2.13 Quick Ratio 03/31/22 - 1.18 12/31/21 - 1.47 09/30/21 - 1.35 Operating Margin 03/31/22 - 20.02 12/31/21 - 20.31 09/30/21 - 21.06 Net Margin 03/31/22 - 11.56 12/31/21 - 11.65 09/30/21 - 11.40 Pre-Tax Margin 03/31/22 - 13.20 12/31/21 - 13.33 09/30/21 - 13.17 Book Value 03/31/22 - 39.79 12/31/21 - 39.42 09/30/21 - 37.60 Inventory Turnover 03/31/22 - 1.82 12/31/21 - 1.80 09/30/21 - 1.74 Debt-to-Equity 03/31/22 - 0.92 12/31/21 - 0.84 09/30/21 - 0.89 Debt-to-Capital 03/31/22 - 47.99 12/31/21 - 45.60 09/30/21 - 47.11

Powered by Zacks Investment Research ©